BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Personalized medicine
,
Lipitor
,
rs2476601
,
DRD2
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CrkL
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Whole blood
Skeletal muscle
T Lymphocyte (regulatory) of peripheral blood
Basophil of peripheral blood
Cerebellum peduncles
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Microbial culture finding
Disorder of thymus gland
DiGeorge sequence
Disorder of parathyroid gland
Bacterial infection due to Bacillus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
dirithromycin
Ipratropium
Ceftazidime
Lindane
lorglumide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-1-3p
Ppp1r15a
AHI1
PLIN1
hsa-miR-365a-3p
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and it…
Crk and Crkl Are Required in the Endocardial Lineage for Heart Valve Development.
Folding and Binding Mechanisms of the SH2 Domain from Crkl.
Crk and CrkL as Therapeutic Targets for Cancer Treatment.
Bifunctional Role of CrkL during Bone Remodeling.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma
PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesyl…
Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL
Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to…
A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ